Jul 28, 2026
1:500
For every 500 shares held, investors received 1. The price per share adjusted from $0.00 to $0.45.
The split itself did not change the total investment value.
Central Asia Lumeichun Biotechnology Inc. (OTC:ZYLM) operates in the Movies/Entertainment industry.
Central Asia Lumeichun Biotechnology Inc. company overviewCentral Asia Lumeichun Biotechnology Inc.'s most recent stock split was on July 28, 2026. It was a 1-for-500 reverse split, so shareholders received 1 share for every 500 they held.
Central Asia Lumeichun Biotechnology Inc. (OTC:ZYLM) has split its stock 5 times: a 1-for-400 reverse split on July 22, 2003, a 1-for-20 reverse split on January 20, 2005, a 1-for-100 reverse split on March 8, 2013, a 1-for-500 reverse split on January 12, 2015, and a 1-for-500 reverse split on July 28, 2026.
Central Asia Lumeichun Biotechnology Inc. has split its stock 5 times. This history records 5 reverse splits between July 22, 2003 and July 28, 2026.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Central Asia Lumeichun Biotechnology Inc.'s 1-for-500 reverse split on July 28, 2026, every 500 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Central Asia Lumeichun Biotechnology Inc. has not announced a new split in our records. Its most recent split was on July 28, 2026, less than a year ago. Companies announce splits in advance, and any new OTC:ZYLM split will appear on this page.